Furthermore, depletion of IGF2BP2 in glioma spheres decreases their oxygen consumption rate through compromising complex I and complex IV activity, which results in impaired clonogenicity in vitro and tumorigenicity in vivo [49]. Here, IGF2BP2 is linked to central nervous system cancer.